substance p has been researched along with camptothecin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Liu, L; Mu, L; Song, J; Wang, K; Wang, R; Xing, Y; Zhang, B; Zhang, W | 1 |
| Huang, S; Jia, B; Kai, M; Song, J; Xie, H; Zhang, W; Zhang, Z | 1 |
2 other study(ies) available for substance p and camptothecin
| Article | Year |
|---|---|
Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Humans; Molecular Structure; Neoplasms; Neurotransmitter Agents; Substance P | 2011 |
SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell-Penetrating Peptides; CHO Cells; Cricetulus; Drug Delivery Systems; Substance P | 2020 |